Dexcom’s CEO Joins Let’s Talk Medtech for a Candid Discussion on Firm’s Future

No topic is off-limits, as Dexcom CEO Kevin Sayer gives an update on the G7 CGM; discusses the competitive landscape; and talks about the collaboration with Nick Jonas.

Omar Ford

June 29, 2021

1 Min Read
Let's Talk Medtech guest Dexcom CEO
Image courtesy of Dexcom



The role of Continuous Glucose Monitoring is growing in diabetes management – and Dexcom aims to be the frontrunner in the space. The San Diego, CA-based company has its G7 CGM on the horizon; solid studies that were presented at the American Diabetes Association 81st Scientific Sessions; diabetes driving telemedicine; and even that Super Bowl Commercial collaboration with Nick Jonas.

Dexcom’s CEO Kevin Sayer checks in for this episode of Let’s Talk Medtech and discusses the company’s recent activities and paints a picture of what the future of CGM will look like.


About the Author(s)

Omar Ford

Omar Ford is MD+DI's Editor-in-Chief. You can reach him at [email protected].


Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like